|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||64.21 - 65.01|
|52-week range||64.21 - 65.01|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||30.74|
|Earnings date||28 Jul 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
DEERFIELD, Ill., June 27, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today released its 2021 Corporate Responsibility Report, demonstrating how the company is progressing toward its 2030 Corporate Responsibility Commitment and Goals. The report highlights the continued progress Baxter has made to advance environmental, social and governance (ESG) performance across its operations and philanthropic programs.
In this article we are going to estimate the intrinsic value of Baxter International Inc. ( NYSE:BAX ) by taking the...
DEERFIELD, Ill., June 08, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.